FineHeart
Manufacturing · France · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Eiffel Bâtiment C 28 Avenue Gustave, Pes...Phone Number
+33 564311840Website
www.fineheart.frRevenue
$37.9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About FineHeart
FineHeart is a clinical-stage medical technology company based in Pessac, France, focused on developing innovative solutions for patients suffering from advanced heart failure. Their flagship product, the ICOMS (Intra Cardiac Output Management System), is an intracardiac pump designed to enhance the native ejection fraction in patients with severe heart failure. The company aims to restore health and improve the quality of life for these patients by providing a new alternative to traditional cardiac assist devices. FineHeart targets healthcare providers and patients in need of effective treatments for severe heart conditions.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is FineHeart your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at FineHeart
Check if FineHeart has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once FineHeart has new funding data
FineHeart, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if FineHeart is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Click to see if FineHeart had a recent Job posting/layoffs
Product Launch: Get notified when FineHeart launches new products
Earning: See what the market has to say on FineHeart recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined FineHeart as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
FineHeart is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
FineHeart is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about FineHeart.
FineHeart financials insights
Gather financial insights about FineHeart, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Series A
$7.2M
2021
Series B
$23.7M
FineHeart Tech Stack
A closer look at the technologies used by FineHeart
See more technologies
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Open Position
Open Position
New Hire
Executive Move
FineHeart News & Media
FineHeart secures $96.6M to support LVAD tech
FineHeart announced that it completed the $40.7 million first closing of its Series C financing round to support its heart failure treatment.FineHeart secures €83m to advance cardiac device development
The French clinical stage company focused on cardiac innovation received the funds from a Series C funding round and the EC’s Med4Cure innovation fund.FineHeart Receives Slovenia JAZMP (Agency for Medicinal Products and Medical Devices of the Republic of Slovenia) Authorization to Launch Its FIH Clinical Study on Patients Suffering From Advanced Heart Failure
BORDEAUX, France & LJUBLJANA, Slovenia--(BUSINESS WIRE)--FineHeart S.A., a clinical-stage medical technology company specializing in the development of innovative solutions for cardiology, announces that it has received authorization from JAZMP, the Agency for Medicinal Products and Medical Devices of the Republic of Slovenia, to begin its First-In-Human (FIH) clinical study. This prospective, non-randomized study is designed to assess the safety, implant feasibility and preliminary clinical peFineHeart Receives ANSM1 Authorization to Deploy Its First-In-Human Clinical Study in France
BORDEAUX, France--(BUSINESS WIRE)--FineHeart S.A., a clinical-stage medical technology company specializing in the development of innovative solutions for cardiology, announces that it has received authorization from the French National Agency for the Safety of Medicines and Health Products (ANSM) to initiate its First-In-Human (FIH) clinical trial in France. This prospective, non-randomized study is designed to assess the safety, implant feasibility and preliminary clinical performance of the
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding FineHeart
Sign Up For FreeTo access detailed company insights
FineHeart is a clinical-stage medical technology company based in Pessac, France, focused on developing innovative solutions for patients suffering from advanced heart failure. Their flagship product, the ICOMS (Intra Cardiac Output Management System), is an intracardiac pump designed to enhance the native ejection fraction in patients with severe... Read More
